Sign in

You're signed outSign in or to get full access.

Luisa Ingargiola

Chief Financial Officer at Avalon GloboCare
Executive

About Luisa Ingargiola

Luisa Ingargiola, age 58, has served as Chief Financial Officer (CFO) of Avalon GloboCare (ALBT) since February 21, 2017. She holds a B.S. in Business Administration (Finance) from Boston University and an MBA in Health Administration from the University of South Florida . Recent “Pay vs Performance” disclosure shows Company TSR of $9 (2023) falling to $4 (2024) for a hypothetical $100 investment, alongside net losses of $(16.7)M (2023) and $(7.9)M (2024), and notes compensation decisions are primarily fixed cash and not tied to TSR or net loss .

Past Roles

OrganizationRoleYearsStrategic Impact
MagneGas Corporation (Nasdaq: MNGA)CFO; later Director2007–2016Public company finance leadership; SEC/compliance experience
Various private companiesBudget Director; Investment AnalystPre‑2007Corporate budgeting and investment analysis experience

External Roles

OrganizationRoleYearsNotes
Dragonfly Energy (Nasdaq: DFLI)Director; Audit ChairCurrentAudit committee leadership
Vision Marine (Nasdaq: VMAR)Director; Audit ChairCurrentAudit committee leadership
XOS Trucks (Nasdaq: XOS)DirectorCurrentDirector
ElectraMeccanica Vehicles (Nasdaq: SOLO)DirectorMar 2018–Jan 2024Former director

Fixed Compensation

Metric202220232024
Base Salary ($)350,000 350,000 350,000
Target Bonus (%)Not disclosedNot disclosedNot disclosed
Actual Bonus Paid ($)— (none disclosed) — (none disclosed) — (none disclosed)

Notes: The Summary Compensation Tables show salary only for Ms. Ingargiola in 2022–2024 with no stock awards, option awards, or non‑equity incentive plan compensation disclosed .

Performance Compensation

Outstanding and Historical Equity Awards

ItemDetail
Option grants (historical)2,000,000 options @ $0.50, 10‑yr term, expiring 2/8/2027; vest in 36 equal tranches commencing grant date
Additional grant (2020)400,000 options @ $1.52, 10‑yr term, expiring 2/18/2030
Outstanding (as of 12/31/2023)200,000 options @ $5.00 exp 2/8/2027; 40,000 options @ $15.20 exp 2/18/2030
Outstanding (as of 12/31/2024)13,333 options @ $75.00 exp 2/8/2027; 2,667 options @ $228.00 exp 2/18/2030
Exercises/VestingNo options exercised and no stock vested in 2024 ; none in 2023 ; none in 2022

Annual/Long-term Incentive Design and Metrics

ElementMetric(s)WeightingTargetActualPayoutVesting
Legacy milestone bonuses (2017 retention)50% salary upon timely 2017 10‑K filing and raising $20M; 100% salary upon (i) merger/sale, (ii) adjusted EBITDA $10M FY, (iii) listing and subsequent $10M raiseN/AAs describedNot disclosedNot disclosedN/A
Ongoing AIP/LTIPCompany states compensation actually paid is principally fixed cash; TSR/net loss not used in plans for periods reportedN/AN/AN/AN/AN/A

Notes: Recent proxies indicate no new equity awards to NEOs in 2024 and no vesting; design disclosures indicate no TSR/net loss metrics driving pay for periods shown .

Equity Ownership & Alignment

ItemAs ofAmountNotes
Total beneficial ownershipOct 31, 202516,000 (options exercisable within 60 days) Less than 1% of shares outstanding
Vested vs unvestedOct 31, 202516,000 vested/exercisable; unvested not disclosed Outstanding awards at 12/31/2024 were shown as exercisable
Options (current expiries)Dec 31, 202413,333 @ $75 (exp 2/8/2027); 2,667 @ $228 (exp 2/18/2030) Reverse splits reflected in strikes/quantities
Pledging/HedgingN/AHedging prohibited by policy Pledging not specifically disclosed
Ownership guidelinesN/ANot disclosed

Employment Terms

  • Role and tenure: CFO since February 21, 2017; Executive Retention Agreement effective February 9, 2017 .
  • At‑will employment; salary increased to $350,000 effective January 1, 2019 .
  • Severance protections:
    • Termination upon a change of control: 12 months base salary plus target bonus (pro‑rated), full acceleration of stock option vesting, and up to 12 months company‑paid health coverage .
    • Involuntary termination: 6 months base salary plus target bonus (pro‑rated), increasing to 12 months after first anniversary; full option vesting acceleration; up to 12 months health coverage .
  • Clawback: Company‑wide clawback policy adopted November 16, 2023 applies to awards under the Amended and Restated 2020 Plan .
  • Non‑compete/Non‑solicit: Not specifically disclosed for Ms. Ingargiola in recent filings .

Governance, Say‑on‑Pay, and Shareholder Feedback

  • Say‑on‑Pay (2023 Annual Meeting): Votes For 5,517,897; Against 32,782; Abstain 6,770; broker non‑votes 1,707,228 .
  • Frequency of Say‑on‑Pay (2023): “One year” received most votes (5,529,740) and was adopted as policy going forward .
  • Anti‑hedging policy in effect for officers, directors, and employees .
  • Compensation Committee is independent and administers equity plans and executive pay .

Related‑Party and Other Risk Indicators

  • Company disclosed related‑party transactions involving the Chairman (line of credit, real estate, preferred stock exchange) and a director’s consulting fees; no related‑party transactions were identified involving Ms. Ingargiola .
  • No option exercises or stock vesting by executive officers in 2024 (and none in 2023/2022), suggesting limited immediate selling pressure from vesting .

Pay vs Performance Context

Metric20232024
Value of $100 initial investment (TSR)9 4
Net Loss ($)(16,707,010) (7,903,394)

Notes: The company states compensation actually paid is principally fixed cash and that neither TSR nor net loss were used as pay metrics for the periods shown .

Investment Implications

  • Pay‑for‑performance alignment: Ms. Ingargiola’s recent compensation is predominantly fixed salary with no disclosed annual bonus payouts and no new equity grants in 2024; disclosed pay plans did not use TSR or net loss as metrics for the periods shown, indicating limited direct alignment to short‑term performance outcomes .
  • Retention vs. change‑of‑control dynamics: The retention agreement provides meaningful severance (6–12 months base plus target bonus) and full option acceleration on involuntary termination or termination in connection with a change of control, which can support retention but could also represent sizable guaranteed economics in transactional scenarios .
  • Insider selling pressure: With no option exercises or stock vesting in 2024 (and none in 2023/2022), and small currently exercisable option holdings (16,000 within 60 days as of Oct 31, 2025), near‑term selling pressure from vesting appears limited based on disclosed data .
  • Alignment and ownership: Beneficial ownership is under 1% of shares outstanding, which may limit direct economic alignment; however, anti‑hedging policy reduces misalignment risk from derivatives .
  • Shareholder sentiment: Strong Say‑on‑Pay support in 2023 and adoption of annual Say‑on‑Pay frequency suggest current investor acceptance of the compensation framework, despite weak TSR over the period disclosed .